About
Vilya is a biotechnology company that leverages a proprietary platform powered by advanced machine learning and generative AI to design novel molecular structures. These de novo macrocycles aim to precisely target disease biology, offering a new class of medicines that combine the advantages of small molecules and antibodies, and are designed to address previously difficult-to-drug therapeutic targets.
Tags
Total Employees
44
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does VILYA do?
Vilya is a biotechnology company that leverages a proprietary platform powered by advanced machine learning and generative AI to design novel molecular structures. These de novo macrocycles aim to precisely target disease biology, offering a new class of medicines that combine the advantages of small molecules and antibodies, and are designed to address previously difficult-to-drug therapeutic targets.
How much funding has VILYA raised?
VILYA has raised a total of $121M in funding. The most recent round on record is Series A.
When was VILYA founded?
VILYA was founded in 2022.
What industry does VILYA operate in?
VILYA operates in BIO + LIFE SCIENCES, Biotech, Drug Discovery, Genomics, AI-Driven Protein Design, HealthTech.
How many employees does VILYA have?
VILYA has approximately 44 people on record.